| Literature DB >> 33978716 |
Peiyu Wang1,2,3, Ligang Zhang1,2,3, Shuiping Yin1,2,3, Yuchen Xu1,2,3, Sheng Tai1,2,3, L I Zhang1,2,3, Chaozhao Liang1,2,3.
Abstract
Circular RNA (circRNA) is a new class of non-coding RNA. It was reported that circRNA involves in the metastasis of cancer. The aim of this study is to explore the role and mechanism of circRNA hsa_circ_0062019 in the development of prostate cancer (PCa). Our results showed that hsa_circ_0062019 was highly expressed in PCa cell lines. Cell Counting Kit-8 assay revealed that upregulation of hsa_circ_0062019 boosted PCa cell proliferation, and silencing of hsa_circ_0062019 inhibited cell proliferation. Meanwhile, transwell assay proved that upregulation of hsa_circ_0062019 facilitated PCa cell invasion and migration, while downregulation of hsa_circ_0062019 inhibited these malignant phenotypes. Furthermore, luciferase reporter assay proved the binding of hsa_circ_0062019 with miR-195-5p and the binding between miR-195-5p and high mobility group AT-hook 2 (HMGA2), suggesting that hsa_circ_0062019 promoted the expression of HMGA2 by sponging miR-195-5p. In addition, our results revealed that the hsa_circ_0062019-induced PCa cell malignant phenotypes were notably reversed by the downregulation of HMGA2. Overall, our study demonstrated that hsa_circ_0062019 promoted PCa cell proliferation, migration, and invasion via upregulation of HMGA2 expression by sponging miR-195-5p. Our study proved a novel molecular mechanism of PCa development and provided a potential target for the treatment of PCa.Entities:
Keywords: competing endogenous RNA; high mobility group AT-hook 2; hsa_circ_0062019; miR-195-5p; prostate cancer
Mesh:
Substances:
Year: 2021 PMID: 33978716 DOI: 10.1093/abbs/gmab058
Source DB: PubMed Journal: Acta Biochim Biophys Sin (Shanghai) ISSN: 1672-9145 Impact factor: 3.848